These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11174114)

  • 1. [New guidelines for evaluating the therapeutic response of solid tumors: try them!].
    Négrier S
    Bull Cancer; 2000 Dec; 87(12):869-70. PubMed ID: 11174114
    [No Abstract]   [Full Text] [Related]  

  • 2. [New recommendations for evaluating the effectiveness of treatment of solid tumors and principles of the Guidelines for Clinical Practice (GCP)].
    Gorbunova VA; Orel NF; Zaruk VA
    Vopr Onkol; 2001; 47(6):718-21. PubMed ID: 11826496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A statistical simulation study finds discordance between WHO criteria and RECIST guideline.
    Mazumdar M; Smith A; Schwartz LH
    J Clin Epidemiol; 2004 Apr; 57(4):358-65. PubMed ID: 15135836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New guidelines to evaluate the response to treatment in solid tumors].
    Duffaud F; Therasse P
    Bull Cancer; 2000 Dec; 87(12):881-6. PubMed ID: 11174117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response evaluation criteria in solid tumors (RECIST): new guidelines.
    Tsuchida Y; Therasse P
    Med Pediatr Oncol; 2001 Jul; 37(1):1-3. PubMed ID: 11466715
    [No Abstract]   [Full Text] [Related]  

  • 6. Criteria for evaluating treatment guidelines.
    American Psychological Association
    Am Psychol; 2002 Dec; 57(12):1052-9. PubMed ID: 12617064
    [No Abstract]   [Full Text] [Related]  

  • 7. Reducing eye pressure slows glaucoma progression.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Nov; 13(22):7-9. PubMed ID: 12643259
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer clinical trial outcomes: any progress in tumour-size assessment?
    Verweij J; Therasse P; Eisenhauer E;
    Eur J Cancer; 2009 Jan; 45(2):225-7. PubMed ID: 19068275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia.
    Creutzig U; Kaspers GJ
    J Clin Oncol; 2004 Aug; 22(16):3432-3. PubMed ID: 15310791
    [No Abstract]   [Full Text] [Related]  

  • 10. Selection of response criteria for clinical trials of sarcoma treatment.
    Schuetze SM; Baker LH; Benjamin RS; Canetta R
    Oncologist; 2008; 13 Suppl 2():32-40. PubMed ID: 18434637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for capture, validation and summarisation of data from studies using RECIST.
    Paules M; Casey M; Williams G; Swann RS; Murphy PS; Salazar VM; Foose D; Bailey B; Therasse P
    Eur J Cancer; 2011 Mar; 47(5):697-701. PubMed ID: 21300537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiating highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children in Europe and the United States: comparing clinical practice to guidelines and literature evidence.
    Verweel G; Saavedra-Lozano J; van Rossum AM; Ramilo O; de Groot R
    Pediatr Infect Dis J; 2006 Nov; 25(11):987-94. PubMed ID: 17072119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapies: cui prodest?
    Ferrari D; Foa P
    J Clin Oncol; 2007 Oct; 25(29):4691-2; author reply 4692. PubMed ID: 17925568
    [No Abstract]   [Full Text] [Related]  

  • 15. [First-in-human clinical trials: comparison of EMEA and FDA guidelines].
    Hernández-López C
    Med Clin (Barc); 2009 Jan; 132(1):30-4. PubMed ID: 19174063
    [No Abstract]   [Full Text] [Related]  

  • 16. Individual patient data analysis to assess modifications to the RECIST criteria.
    Bogaerts J; Ford R; Sargent D; Schwartz LH; Rubinstein L; Lacombe D; Eisenhauer E; Verweij J; Therasse P;
    Eur J Cancer; 2009 Jan; 45(2):248-60. PubMed ID: 19095437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response assessment classification in patients with advanced renal cell carcinoma treated on clinical trials.
    Schwartz LH; Mazumdar M; Wang L; Smith A; Marion S; Panicek DM; Motzer RJ
    Cancer; 2003 Oct; 98(8):1611-9. PubMed ID: 14534876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?
    Forner A; Ayuso C; Varela M; Rimola J; Hessheimer AJ; de Lope CR; Reig M; Bianchi L; Llovet JM; Bruix J
    Cancer; 2009 Feb; 115(3):616-23. PubMed ID: 19117042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RECIST revisited: a review of validation studies on tumour assessment.
    Therasse P; Eisenhauer EA; Verweij J
    Eur J Cancer; 2006 May; 42(8):1031-9. PubMed ID: 16616487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latest US KDOQI Anaemia Guidelines update--what are the implications for Europe?
    Macdougall IC; Eckardt KU; Locatelli F
    Nephrol Dial Transplant; 2007 Oct; 22(10):2738-42. PubMed ID: 17906324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.